The results are indicative of no impact of methoxyfenozide and flonicamid on the two natural enemies in the field, and both can be considered as potential alternatives to be included in IPM programmes in sweet pepper.
Successful integrated pest management in protected crops implies an evaluation of the compatibility of pesticides and natural enemies (NE), as control strategies that only rely on one tactic can fail when pest populations exceed NE activity or pests become resistant to pesticides. Nowadays in Almería (Spain), growers release NE prior to transplanting or early in the crop cycle to favor their settlement before pest arrival because this improves biocontrol efficacy, although it extends pesticide exposure periods. The purpose of this research was to evaluate the compatibility of two applications of pesticides with key NE in 2‐year trials inside tomato and sweet pepper commercial greenhouses: Nesidiocoris tenuis (Reuter) (Hemiptera: Miridae), Orius laevigatus (Say) (Hemiptera: Anthocoridae) and Amblyseius swirskii (Athias‐Henriot) (Acari: Phytoseiidae). In tomato, flubendiamide and chlorantraniliprole (IOBC category 1) were compatible with N. tenuis, but chlorpyrifos‐methyl and spinosad (IOBC categories 2–3), which effectively reduced Tuta absoluta (Meyrick) (Lepidoptera: Gelechiidae) density, compromised its predatory activity. In sweet pepper, chlorantraniliprole (IOBC category 1) was the only pesticide compatible with O. laevigatus while chlorantraniliprole, emamectin benzoate, spirotetramat and pymetrozine were harmless (IOBC category 1) to Amblyseius swirskii, and sulfoxaflor slightly harmful (IOBC category 2) to this phytoseiid predator.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.